1. Home
  2. NTWK vs GNTA Comparison

NTWK vs GNTA Comparison

Compare NTWK & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NetSol Technologies Inc.

NTWK

NetSol Technologies Inc.

HOLD

Current Price

$2.95

Market Cap

35.5M

Sector

Technology

ML Signal

HOLD

Logo Genenta Science S.p.A.

GNTA

Genenta Science S.p.A.

HOLD

Current Price

$1.44

Market Cap

34.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTWK
GNTA
Founded
1997
2014
Country
United States
Italy
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
35.5M
34.0M
IPO Year
1998
2021

Fundamental Metrics

Financial Performance
Metric
NTWK
GNTA
Price
$2.95
$1.44
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
42.7K
96.3K
Earning Date
02-12-2026
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.04
N/A
Revenue
$66,501,654.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$74.92
N/A
Revenue Growth
7.70
N/A
52 Week Low
$2.14
$1.28
52 Week High
$5.75
$10.00

Technical Indicators

Market Signals
Indicator
NTWK
GNTA
Relative Strength Index (RSI) 39.60 36.43
Support Level $2.96 $1.28
Resistance Level $3.13 $1.59
Average True Range (ATR) 0.15 0.19
MACD 0.03 0.03
Stochastic Oscillator 0.00 22.45

Price Performance

Historical Comparison
NTWK
GNTA

About NTWK NetSol Technologies Inc.

NETSOL Technologies Inc is an information technology and enterprise software solutions provider to original equipment manufacturers (OEMs), dealerships, and financial institutions to sell, finance, and lease assets. The firm's products include Transcend Retail, Transcend Finance, Transcend Marketplace, Transcend Consultancy, and Transcend AI Labs, catering to its customers in the different stages of how assets are sold, financed, and leased. Its primary sources of revenue are licensing, subscriptions, modification, enhancement, and support of its suite of financial applications offered to businesses in the finance and leasing space, as well as automotive digital retail. The company has three reportable segments: Asia-Pacific, its key revenue-generating market, North America, and Europe.

About GNTA Genenta Science S.p.A.

Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.

Share on Social Networks: